Selected Tag

Peter Reese

All Tags 89

Learning How Behavioral Economics Impacts Health Decisions

    • Quit Smoking
    • senior couple on walk
    • laptop computer
    • Seated Exercise
    • Ladies Swimming
  • Previous
  • Next

Center for Health Incentives and Behavioral Economics Research

CHIBE researchers apply concepts from the field of behavioral economics to design, implement, and evaluate interventions that improve health and build knowledge about efficacy, cost and effectiveness. 

Basic Science Core Request for Applications

The Basic Science Core aims to support laboratory or low-cost field studies that will shed light on mechanisms that can generate behavior change.  In contrast to previous large-scale field studies, which have often combined multiple mechanisms into one intervention in order to maximize impact on behavior, basic science projects supported by the Core focus on disentangling and precisely identifying the impacts of individual mechanisms.  CHIBE researchers interested in applying for project support can click here for more information.



Health Incentives and Behavioral Economics Research Studies

You are viewing 9 posts with the tag Peter Reese

Using Social Forces to Improve Medication Adherence in Statin Users With Diabetes

Principal Investigators: Kevin Volpp, MD, PhD, Judd Kessler, PhD, Peter Reese, MD, MSCE

There is growing evidence of strong associations between a patient’s social environment and health behavior.  Social forces are worth harnessing as a strategy to promote health behaviors because patients usually engage with their physicians and nurses during occasional health system visits, but they interact with their social networks much more frequently. Furthermore, social forces may be particularly effective at building enduring habits for healthy behavior and might be cost effective to implement.  This study proposes to complete a randomized controlled trial of 200 subjects with diabetes and evidence of poor adherence to a statin medication (<70% medication possession ratio determined through pharmacy records). Study subjects will use GlowCaps to store their statin medication. Study subjects will identify potential Medication Adherence Partners (MAPs) who can receive information about their adherence patterns at enrollment. The primary outcome will be the percent of statin doses taken during the study as measured by the GlowCaps. The secondary outcome will be subjects’ statin MPR during the study.

Funder: Merck & Co.

Using Social Comparison to Improve Medication Adherence in Statin Users With Diabetes

Principal Investigators: Kevin Volpp, MD, PhD, Judd Kessler, PhD, Peter Reese, MD, MSCE

This study aims to investigate the association between a patient’s social environment and health behaviors. It has been well documented in non-health domains that providing agents with information about what others are doing can be an effective motivator. Leveraging this social force might be capable of encouraging patients to build habits for healthy behavior and might be cost effective to implement. This study specifically leverages feedback and information about the performance of others to influence individual behavior. An individual can be motivated to improve his performance when he knows he will be receiving feedback about that performance. Additionally, individuals may feel compelled to compete when their performance is compared to the performance of others. This study’s interventions will study the effects of feedback and information about others by varying what individuals are told about their medication adherence and how it compares to other people in the study. 

Funder: Merck & Co.

Project LIFT: Lifestyle intervention to promote fitness in transplantation

Principal Investigators: Marina Serper, MD, MS; Iwan Barankay, PhD; Peter Reese, MD

Objectives: 1) To determine whether use of an accelerometer device (Misfit tracker) and financial loss-incentives paired with health trivia information vs. the accelerometer use alone increases walking among kidney and liver transplant recipients, and 2) To evaluate whether the interventions are associated with lower weight and changes in body fat composition.

Funder: CTSA UL1TR000003 from the National Center for Advancing Translational Science

Process Versus Outcomes Incentives for Lipid Management

Principal Investigators: Peter Reese, MD; Kevin Volpp, MD, PhD

Financial incentives have been shown to be effective at improving patient health behaviors including medication adherence in a wide variety of contexts. The delivery of such incentives has been enhanced by the recent development of new wireless technologies that facilitate the measurement of daily medication adherence and the provision of incentives in an automated fashion. However, the relative effectiveness of incentives based on process (e.g. statin adherence) versus outcome (e.g. improvements in LDL cholesterol) is unknown.This is a randomized controlled trial to evaluate the relative effectiveness and cost-effectiveness of improving cholesterol levels among participants who are at high risk of CVD and who have elevated LDL cholesterol levels by testing process versus outcomes financial incentives. 

Funder: National Heart, Lung and Blood Institute

Donor Registration Trial

Principal Investigator: Peter Reese, MD

This Roybal pilot is a randomized, controlled trial to compare the effects of four interventions on the rate of organ donor registration by members of the general public who visit the DMV website for business unrelated to organ donor registration.

Funded by: Roybal P30 Pilot

Testing Behavioral Economic Interventions to Improve Statin Use and Reduce CVD Risk

Principal Investigators: Kevin Volpp, Iwan Barankay, Peter Reese

The application of conceptual approaches from behavioral economics offers considerable promise in advancing health and health care. In patients with suboptimal cholesterol control who are at high risk for CVD, this study will test the effectiveness and cost-effectiveness of different behavioral economic techniques to improve statin adherence following discontinuation of the intervention. Investigative team leaders Iwan Barankay, Kevin Volpp and Peter Reese will use a 4-arm randomized controlled trial to compare the effectiveness and cost effectiveness of alternative approaches to inducing habit formation among CVD patients with poorly controlled cholesterol who have been prescribed statins.

Funded by: NIH/National Institute on Aging

Payment for Living Kidney Donation: An Undue or Unjust Inducement?

Principal Investigators: Reese / Halpern

This research aims to test empirical assumptions about human decision-making with respect to kidney donation among urban community members and those being evaluated for kidney donation at a large city hospital. The influences of the risk of kidney donation, the payment to be offered, and the recipient of the kidney (family member vs. anonymous recipient) on the subjects’ willingness to donate will be evaluated.

Measuring living kidney transplantation at renal transplant centers: Magnitude, determinants and consequences

Principal Investigator: Reese

Variation in live donor kidney transplantation across transplant centers. 

Funded by: National Institutes of Health 

Tags: NIH, Peter Reese

T. Franklin Williams Award in Geriatric Research

Principle Investigator: Reese

Examination of the effects of emerging organ allocation proposals on older kidney transplant candidates.

Funded by: Association of Specialty Professors and American Society of Nephrology